Publications by authors named "W Haw"
Article Synopsis
- Recent clinical practice guidelines (CPGs) for managing urticaria were reviewed to assess their quality and identify gaps in treatment recommendations for chronic spontaneous urticaria.
- A total of 21 CPGs were analyzed, primarily from European and Asian countries, revealing that 81% scored poorly in critical appraisal domains such as applicability and stakeholder involvement.
- Most guidelines displayed potential biases, with 86% raising serious concerns about the involvement of experts and external review, and 95% failing to meet established trustworthiness standards in areas like updating procedures.
Introduction: Alopecia areata (AA) is a nonscarring alopecia with an estimated global prevalence of 2% and limited data on the efficacy of current treatment. Clinical practice guidelines (CPGs) provide recommendations based on best available evidence. It is unclear how many AA CPGs are available globally.
View Article and Find Full Text PDFOne of the most severe forms of cutaneous adverse drug reactions is "drug reaction with eosinophilia and systemic symptoms" (DRESS), hence subsequent avoidance of the causal drug is imperative. However, attribution of drug culpability in DRESS is challenging and standard skin allergy tests are not recommended due to patient safety reasons. Whilst incidence of DRESS is relatively low, between 1:1000 and 1:10 000 drug exposures, antibiotics are a commoner cause of DRESS and absence of confirmatory diagnostic test can result in unnecessary avoidance of efficacious treatment.
View Article and Find Full Text PDFBackground: Clinical practice guidelines (CPGs) developed with rigorous methods can help optimize clinical care for patients with psoriasis.
Objectives: To conduct an updated systematic review and comprehensive critical appraisal of global psoriasis CPGs.
Methods: A search of MEDLINE and Embase for psoriasis CPGs published between 1 January 2015 and 31 March 2021 was performed.
Background: Clinical practice guidelines (CPGs) play a critical role in standardizing and improving treatment outcomes based on the available evidence. It is unclear how many CPGs are available globally to assist clinicians in the management of patients with skin disease.
Objectives: To search for and identify CPGs for dermatological conditions with the highest burden globally.